{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:36:45Z","timestamp":1780472205466,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,7,25]],"date-time":"2016-07-25T00:00:00Z","timestamp":1469404800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Medical University of Lodz, Poland","award":["No: 502-03\/8-000-01\/502-64-030 and 503\/0-079-05\/5"],"award-info":[{"award-number":["No: 502-03\/8-000-01\/502-64-030 and 503\/0-079-05\/5"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s10067-016-3355-1","type":"journal-article","created":{"date-parts":[[2016,7,25]],"date-time":"2016-07-25T15:54:20Z","timestamp":1469462060000},"page":"2699-2706","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Anti-MCV and anti-CCP antibodies\u2014diagnostic and prognostic value in children with juvenile idiopathic arthritis (JIA)"],"prefix":"10.1007","volume":"35","author":[{"given":"Joanna","family":"Lipinska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislawa","family":"Lipinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Kasielski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elzbieta","family":"Smolewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,25]]},"reference":[{"key":"3355_CR1","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/B978-1-4160-0246-8.50015-2","volume-title":"Textbook of pediatric rheumatology.","author":"JT Cassidy","year":"2005","unstructured":"Cassidy JT, Lindsley CB (2005) Chronic arthritis in childhood. In: Cassidy JT, Petty RE, Laxer RM, Lindsley CB (eds) Textbook of pediatric rheumatology. Elsevier Saunders, Philadelphia, pp. 206\u2013260"},{"key":"3355_CR2","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(07)60363-8","volume":"369","author":"A Ravelli","year":"2007","unstructured":"Ravelli A, Martini A (2007) Juvenile chronic arthritis. Lancet 369:767\u2013778","journal-title":"Lancet"},{"key":"3355_CR3","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1136\/ard.2010.133033","volume":"69","author":"A Martini","year":"2010","unstructured":"Martini A, Lovell DJ (2010) Juvenile idiopathic arthritis: state of the art and future perspectives. Ann Rheum Dis 69:1260\u20131263","journal-title":"Ann Rheum Dis"},{"key":"3355_CR4","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, International League of Associations for Rheumatology, et al. (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390\u2013392","journal-title":"J Rheumatol"},{"issue":"2","key":"3355_CR5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/ard.2008.103283","volume":"69","author":"JJ Luime","year":"2010","unstructured":"Luime JJ, Colin EM, Hazes JM, Lubberts E (2010) Does anti-mutated citrullinated vimentin have additional value as a serological marker in the diagnostic and prognostic investigation of patients with rheumatoid arthritis? A systematic review. Ann Rheum Dis 69(2):337\u2013344","journal-title":"Ann Rheum Dis"},{"issue":"1\u20132","key":"3355_CR6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cca.2011.10.020","volume":"413","author":"AT Kuna","year":"2012","unstructured":"Kuna AT (2012) Mutated citrullinated vimentin antibodies in rheumatoid arthritis. Clin Chim Acta 413(1\u20132):66\u201373","journal-title":"Clin Chim Acta"},{"issue":"12","key":"3355_CR7","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1136\/annrheumdis-2013-203510","volume":"72","author":"C Turesson","year":"2013","unstructured":"Turesson C, Mathsson L, Jacobsson LT, Sturfelt G, R\u00f6nnelid J (2013) Antibodies to modified citrullinated vimentin are associated with severe extra-articular manifestations in rheumatoid arthritis. Ann Rheum Dis 72(12):2047\u20132048","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"3355_CR8","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/annrheumdis-2011-201056","volume":"72","author":"P Nicaise-Roland","year":"2013","unstructured":"Nicaise-Roland P, Nogueira L, Demattei C, de Chaisemartin L, Rincheval N, Cornillet M, et al. (2013) Autoantibodies to citrullinated fibrinogen compared with anti-MCV and anti-CCP2 antibodies in diagnosing rheumatoid arthritis at an early stage: data from the French ESPOIR cohort. Ann Rheum Dis 72(3):357\u2013362","journal-title":"Ann Rheum Dis"},{"key":"3355_CR9","doi-asserted-by":"crossref","unstructured":"Avdeeva AS, Aleksandrova EN, Novikov AA, Smirnov AV, Cherkasova MV, Nasonov EL. The relationship of antibodies to modified citrullinated vimentin and markers of bone and cartilage destruction in rheumatoid arthritis. Int J Rheumatol 2014;2014:464585.","DOI":"10.1155\/2014\/464585"},{"issue":"5","key":"3355_CR10","first-page":"622","volume":"32","author":"O Derganova","year":"2014","unstructured":"Derganova O, Martinez-Gamboa L, Egerer K, Bang H, Fredenhagen G, Roggenbuck D, et al. (2014) Selected cyclic citrullinated peptides derived from the sequence of mutated and citrullinated vimentin (MCV) are targeted by different antibodies subclasses in patients with rheumatoid arthritis in Russian patients. Clin Exp Rheumatol 32(5):622\u2013629","journal-title":"Clin Exp Rheumatol"},{"key":"3355_CR11","first-page":"198198","volume":"2014","author":"ML D\u00edaz-Toscano","year":"2014","unstructured":"D\u00edaz-Toscano ML, Olivas-Flores EM, Zavaleta-Mu\u00f1iz SA, Gamez-Nava JI, Cardona-Mu\u00f1oz EG, Ponce-Guarneros M, et al. (2014) Comparison of two assays to determine anti-citrullinated peptide antibodies in rheumatoid arthritis in relation to other chronic inflammatory rheumatic diseases: assaying anti-modified citrullinated vimentin antibodies adds value to second-generation anti-citrullinated cyclic peptides testing. Biomed Res Int 2014:198198","journal-title":"Biomed Res Int"},{"key":"3355_CR12","doi-asserted-by":"crossref","unstructured":"Reyes-Castillo Z, Palafox-S\u00e1nchez CA, Parra-Rojas I, Mart\u00ednez-Bonilla GE, Del Toro-Arreola S, Ram\u00edrez-Due\u00f1as MG, et al. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features. Clin Exp Immunol 2015;182(2):119\u2013131.","DOI":"10.1111\/cei.12677"},{"issue":"5","key":"3355_CR13","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.3899\/jrheum.110879","volume":"39","author":"J Lipinska","year":"2012","unstructured":"Lipinska J, Br\u00f3zik H, Stanczyk J, Smolewska E (2012) Anticitrullinated protein antibodies and radiological progression in juvenile idiopathic arthritis. J Rheumatol 39(5):1078\u20131087","journal-title":"J Rheumatol"},{"issue":"1","key":"3355_CR14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1546-0096-10-29","volume":"10","author":"AE Tebo","year":"2012","unstructured":"Tebo AE, Jaskowski T, Davis KW, Whiting A, Clifford B, Zeft A, et al. (2012) Profiling anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis. Pediatr Rheumatol Online J 10(1):29","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"3355_CR15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jbspin.2012.03.008","volume":"80","author":"A Omar","year":"2013","unstructured":"Omar A, Abo-Elyoun I, Hussein H, Nabih M, Atwa H, Gad S, et al. (2013) Anti-cyclic citrullinated peptide (anti-CCP) antibody in juvenile idiopathic arthritis (JIA): correlations with disease activity and severity of joint damage (a multicenter trial). Joint Bone Spine 80(1):38\u201343","journal-title":"Joint Bone Spine"},{"issue":"Suppl 1","key":"3355_CR16","doi-asserted-by":"crossref","first-page":"P67","DOI":"10.1186\/1546-0096-6-S1-P67","volume":"6","author":"D Guseinova","year":"2008","unstructured":"Guseinova D, Lazareva A, Shantere R, Berzinja D, Rasnachs O, Stanevicha V (2008) The value of antibodies against mutated citrullinated vimentin in juvenile idiopathic arthritis. Pediatr Rheumatol Online J 6(Suppl 1):P67","journal-title":"Pediatr Rheumatol Online J"},{"issue":"12","key":"3355_CR17","first-page":"1525","volume":"47","author":"AT Kuna","year":"2009","unstructured":"Kuna AT, Lamot L, Miler M, Harjacek M, Simundic AM, Vrkic N (2009) Antibodies to mutated citrullinated vimentin and antibodies to cyclic citrullinated peptides in juvenile idiopathic arthritis. Clin Chem Lab Med 47(12):1525\u20131530","journal-title":"Clin Chem Lab Med"},{"issue":"5","key":"3355_CR18","first-page":"800","volume":"28","author":"H Morbach","year":"2010","unstructured":"Morbach H, Dannecker H, Kerkau T, Girschick HJ (2010) Prevalence of antibodies against mutated citrullinated vimentin and cyclic citrullinated peptide in children with juvenile idiopathic arthritis. Clin Exp Rheumatol 28(5):800","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"3355_CR19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1546-0096-11-31","volume":"11","author":"BE Gilliam","year":"2013","unstructured":"Gilliam BE, Chauhan AK, Moore TL (2013) Evaluation of anti-citrullinated type II collagen and anti-citrullinated vimentin antibodies in patients with juvenile idiopathic arthritis. Pediatr Rheumatol Online J 11(1):31","journal-title":"Pediatr Rheumatol Online J"},{"issue":"2","key":"3355_CR20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/rheumatology\/ket310","volume":"53","author":"M Bulatovi\u0107 Calasan","year":"2014","unstructured":"Bulatovi\u0107 Calasan M, de Vries LD, Vastert SJ, Heijstek MW, Wulffraat NM (2014) Interpretation of the Juvenile Arthritis Disease Activity Score: responsiveness, clinically important differences and levels of disease activity in prospective cohorts of patients with juvenile idiopathic arthritis. Rheumatology (Oxford) 53(2):307\u2013312","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"3355_CR21","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1002\/art.21119","volume":"52","author":"S Viola","year":"2005","unstructured":"Viola S, Felici E, Magni-Manzoni S, Pistorio A, Buoncompagni A, Ruperto N, et al. (2005) Development and validation of a clinical index for assessment of long-term damage in juvenile idiopathic arthritis. Arthritis Rheum 52(7):2092\u20132102","journal-title":"Arthritis Rheum"},{"issue":"11","key":"3355_CR22","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.autrev.2012.02.015","volume":"11","author":"E Bartoloni","year":"2012","unstructured":"Bartoloni E, Alunno A, Bistoni O, Bizzaro N, Migliorini P, Morozzi G, Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) investigators, et al. (2012) Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature. Autoimmun Rev 11(11):815\u2013820","journal-title":"Autoimmun Rev"},{"issue":"2","key":"3355_CR23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s13317-010-0013-5","volume":"1","author":"M Fabris","year":"2010","unstructured":"Fabris M, De Vita S, Blasone N, Visentini D, Pezzarini E, Pontarini E, et al. (2010) Serum levels of anti-CCP antibodies, anti-MCV antibodies and RF IgA in the follow-up of patients with rheumatoid arthritis treated with rituximab. Auto Immun Highlights 1(2):87\u201394","journal-title":"Auto Immun Highlights"},{"issue":"10","key":"3355_CR24","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1136\/annrheumdis-2011-200848","volume":"71","author":"MK Koivula","year":"2012","unstructured":"Koivula MK, Heli\u00f6vaara M, Rissanen H, Palosuo T, Knekt P, Immonen H, et al. (2012) Antibodies binding to citrullinated telopeptides of type I and type II collagens and to mutated citrullinated vimentin synergistically predict the development of seropositive rheumatoid arthritis. Ann Rheum Dis 71(10):1666\u20131670","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"3355_CR25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040362","volume":"7","author":"G Ferraccioli","year":"2012","unstructured":"Ferraccioli G, Tolusso B, Bobbio-Pallavicini F, Gremese E, Ravagnani V, Benucci M, et al. (2012) Biomarkers of good EULAR response to the B cell depletion therapy in all seropositive rheumatoid arthritis patients: clues for the pathogenesis. PLoS One 7(7):e40362","journal-title":"PLoS One"},{"key":"3355_CR26","unstructured":"Reis J, Aguiar F, Brito I (2016) Anti CD20 (rituximab) therapy in refractory pediatric rheumatic diseases. Acta Reumatol Port 41(1):45\u201355"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3355-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-016-3355-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3355-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T19:07:02Z","timestamp":1498331222000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-016-3355-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,25]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["3355"],"URL":"https:\/\/doi.org\/10.1007\/s10067-016-3355-1","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,25]]}}}